mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |